Palatin (PTN) Q3 2025 Earnings Call May 14, 2025 11:00 AM ET Company Participants Carl Spana - Co-Founder, President, CEO & DirectorStephen Wills - CFO, COO, Secretary & Treasurer Conference Call Participants Scott Henry - Managing Director & Senior Research Analyst Operator Greetings. Welcome to Palatin's Third Quarter Fiscal Year twenty twenty five Operating Results Conference Call. At this time, all participants are in a listen only mode. A question and answer session will follow the formal presentation. ...

Six-month open-label study showed clinically meaningful improvements in kidney function and disease in patients with Type 2 diabetic nephropathy. 71% achieved a >30% reduction in UP/Cr, a key indicator of kidney damage. 71% demonstrated improved or stabilized eGFR, signaling preserved kidney function. 37.5% had increased urinary VEGF levels, suggesting better blood vessel support in the kidneys. 36% had reduced urinary synaptopodin losses, indicating healthier kidney cells and structure. CRANBURY, N.J., A ...

Palatin (PTN) Q2 2025 Earnings Call February 13, 2025 11:00 AM ET Company Participants Carl Spana - Co-Founder, President, CEO & DirectorStephen Wills - Executive Vice President, Chief Financial Officer and Chief Operating OfficerJoe Pantginis - Managing Director Operator Greetings. Welcome to Palatin's Second Quarter Fiscal Year twenty twenty five Operating Results Conference Call. At this time, all participants are in a listen only mode. A question and answer session will follow the formal As a reminder, ...